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Abstract
It is recognised that radiotherapy provides relief for intractable pain in approximately 50% of patients with cancer pain. Unfortunately, 
traditional explanatory variables, such as age, gender, histology or radiation dose, do not help to predict which individuals will benefit 
from palliative radiotherapy. A non-randomised prospective clinical trial was conducted on 51 patients to evaluate the value of pain 
characteristics as new explanatory variables for predicting the efficacy of palliative radiotherapy for providing cancer pain relief. Two 
new explanatory variables were identified: the presence of radiating pain and the pain score before radiotherapy.
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1. Introduction
About 40% of patients who are referred for radiotherapy 
have advanced stage cancer which does not respond to 
curative treatment (WHO Expert Committee, 1990) and 
is accompanied by pain (Torpie, 1987), In the literature, 
there is wide variation in the response rates of patients 
treated with radiotherapy for pain relief: 1 1 % failure rate 
(Salazar et al., 1981), 80% overall response rate (Hoskin, 
1988) and 50% mean complete response rate (Hoskin, 
1988). In view of the prospect of short-term survival, 
severe pain and the wish to spare such patients the extra 
burden of ineffective treatment it is of great importance to 
be able to predict the response to palliative radiotherapy.
Until now, tumour characteristics (e.g., primary histol­
ogy, stage, localisation of metastases (Hendrickson et al., 
1976; Gilbert et al., 1977; Arcangeli et al, 1989) and the 
radiotherapy method (e.g., dose and fractionation regi­
mens; Allen et al., 1976; Tong et al., 1982; Madsen, 
1983; Blitzer, 1985; Price et al., 1986; Tombolini et al.,
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1994) have served as explanatory variables for predicting 
whether radiotherapy will provide pain relief. However, 
there is little support for the notion that either.one of 
these indices or even tumour shrinkage are related to 
pain relief by radiotherapy (Torpie, 1987; Hoskin, 1991).
Recently, data from our animal experiments have shown 
that irradiation inhibits behavioural responses to repeated 
noxious stimulation (Rutten et al, 1994) and we found 
evidence to suggest that irradiation modified the proces­
sing of pain signals. If the considerations on the mechan­
isms of effect are also applicable to the human condition of 
cancer and pain, then the characteristics of pain itself may 
help to predict whether radiotherapy will be effective.
In a non-randomised prospective clinical study, we 
evaluated the value of pain characteristics as new expla­
natory variables for predicting the efficacy of radiother­
apy.
2. Patients and methods
Patients with cytological or histological evidence of 
incurable malignant disease and with pain associated 
with the primary tumour or a metastasis, who had received 
palliative treatment for pain at the department of radio-
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therapy of the University Hospital Nijmegen were selected 
for the purpose of this prospective study (n = 75). Exclu­
sion criteria were younger than 16 years of age, pain not 
related to the tumour or metastases and an earlier palliative 
radiotherapy treatment effort for pain relief.
Pretreatment evaluation included registration, an exten­
sive interview and physical examination. Details about the 
malignant disease, previous therapeutic efforts, pain and 
the use of analgesics were noted. After receiving a detailed 
explanation, the patients were asked to fill in a pain ques­
tionnaire on a daily basis for 28 days. Recording started on 
the first day of palliative radiotherapy and the patients 
handed in their results at weekly intervals. Participants 
were asked not to modify their medication intake during 
the evaluation period.
2.7. Radiotherapy
Radiotherapy was applied as an 8 Gy tumour dose in a 
single fraction or as a 20, 30 or 40 Gy tumour dose in daily 
fractions of 4, 3 or 2 Gy, respectively. The treatment pol­
icy was prescribed by the radiotherapist and was based on 
the general condition of the patient. A patient with a stable 
general condition with an imminent fracture was treated 
with a multi-fraction policy, while patients with a poor 
general condition were irradiated with a single fraction 
of 8 Gy.
No adjustments were made for the radiation energy, but 
when 250 kV X-rays were applied, correction was made 
for the relative biological effect. Parallel opposing fields 
were used for the vertebral column, hip, pelvis and long 
bones; direct fields for the ribs. Doses were prescribed to 
the mid-plane for parallel opposing fields.
2.2. Measures
Pain intensity was rated on a numeric rating scale (NRS) 
from 0 to 100 (0 = no pain, 100 = maximum severity). 
Pain was classified as nociceptive, neurogenic, idiopathic 
or psychogenic (Merskey and Bugdok, 1994). The efficacy 
of radiotherapy was classified as complete, partial or no 
response.
The size of the response was measured by comparing 
the mean NRS of the first two days of the observation 
period to the mean NRS of the two last days of the obser­
vation period.
Response was defined as complete if full pain relief 
(NRS = 0) was attained within the evaluation period of 
28 days. This response could be achieved at any day during 
the observation period, and sustained until the end of the 
observation period. Partial response was defined as a dif­
ference of 20 or more between the mean NRS scores 
recorded on the first two days and the last two days of 
the observation period, while no response was defined as 
a difference of less than 20 points.
2.3. Explanatory variables
Four groups of putative explanatory variables were 
formed: (a) patient characteristics which included age, 
gender and performance based on the ECOG scale; (b) 
tumour characteristics which included primary localisa­
tion, localisation of metastases, M stage and anti-tumour 
medication; (c) radiotherapy characteristics which includ­
ed dose, field size and treatment site; and (d) pain char­
acteristics which included the number of hours that a 
patient experienced pain (pain hours) divided into two 
categories of <12 h and >12  h, the level of pain before 
radiotherapy (NRS score), the presence/absence of radiat­
ing pain, and the type of the pain. The criteria used for 
radiating pain were: (a) any pain projected into the inner­
vation pathway; and (b) any pain extending beyond the 
limits of the primary site.
2 A. Analysis
Logistic regression analysis was used to investigate the 
relationship between the response probability and the 
explanatory variables. Response was defined as complete 
or incomplete (i.e., partial or no response).
Analyses were performed for each variable separately 
and for the four groups of explanatory variables. A logistic 
regression model was constructed and its predictive capa­
city was evaluated.
Statistical analysis was performed using SAS/STAT 
version 6.07, SAS Institute Inc., Cary, NC, USA.
3. Results
A total of 75 patients met our inclusion criteria for the 
study. However, the physical condition of 24 participants 
deteriorated rapidly and they were unable to complete 
treatment. Therefore, the data on 51 patients could be 
analysed. Primary tumour site and patient characteristics 
are shown in Tables 1 and 2.
Before radiotherapy 33% of the patients had an NRS of 
70 or more, 47% between 35 and 70, and 20% less or equal 
to 35. Four patients had neurogenic pain, 21 patients noci­
ceptive pain and 26 a combination of neurogenic and noci­
ceptive pain.
3.1. Response to radiotherapy
Complete response was observed in 12 (23.5%) patients 
(NRS = 0) and partial response in 18 (35.2%) patients ancl 
no response in 21 (42%). The pain score versus time for 
the two types of response is shown in Fig. 1. Complete 
response occurred within 21 days of the start of radiother­
apy and the result was not due to any changes in the con­
sumption of analgesics. Analgesic consumption remained 
stable for all patients.
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Table 1
Primary site of malignancy and response to palliative radiotherapy
Site of primary tumour No. of patients
Complete
response
Partial/ 
no response
Primary unknown 1 1
ENT 1 2
Oesophagus 1 1
Colon 1 —
Rectum — 1
Lung — 6
Pleura — 1
Lymphomas 1 3
Skin 1 —
Breast 4 11
Ovary 1
Prostate 2 6
Bladder — 2
Kidney — 3
Thyroid 1
3,2. Explanatory variables
No significant relationships were found between the 
response probability and any of the separate explanatory
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Fig. 1. Analgesic response after radiotherapy.
variables using logistic regression analysis (P > 0.05, like- 
lihood ratio test). When the explanatory variables were 
analysed in groups, a significant relationship was found 
between the response probability and the pain character­
istics: the presence of radiating pain and the pain score 
before radiotherapy (P < 0.1; Table 3). Using these two 
variables, the chance of achieving a complete response (pc) 
can be calculated as:
Table 2
Patient characteristics
No. of patients
Complete Partial No
response response response
Age (years, mean ±  SD) 54 ± 11.5 56 ± 9.9 60 ± 11.7
Gender
Male 8 11 10
Female 4 7 11
ECOG (0-4)
0 9 9 17
>0 (1-3) 3 9 4
Co-therapy
None/hormone 6 11 15
Chemotherapy 6 7 6 .
Métastasés
No 1 2 2
Yes 9 16 17
Radiotherapy, total dose
1-8 Gy 2 6 2
9-29 Gy 10 4 16
>30 Gy 0 8 3
Bone métastasés
No 1 4 0
Yes 11 13 19
Logit (pc) = -2.3 + 2.2 (radiating pain)
- 1.6 (pain num score)
where p c is the probability of achieving a complete 
response. Patients with radiating pain and a pain score 
before radiotherapy of less than or equal to 35 had the
Table 3
Dichotomy and P values of patients who showed a complete response 
0» = 12) versus partial or no response (n ~ 39)
Group Explanatory
variable
Dichotomy P  value inside 
the category
Patient Age <60, >60 0.32
Gender Male, female
ECOG >0.1
Tumour Gender x breast 0.1 0.84
cancer
Co-therapy None/1] ormonal
chemotherapy/
other
Métastasés No, yes
Bone métastasés No, yes
Pain Pain duration £12, 12 0.02
Radiating pain No, yes
Pain NRS £35, >35
Pain type Nociceptive,
neurogenic
Radiotherapy Total dose £8, >8 0.57
Field size (cm“) £165, >165
Treatment site Spine, no spine
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best prognosis; 17 patients met these criteria and 8 of them 
showed a complete response. The overall correct classifi­
cation was 75% (38/51),
4. Discussion
The majority of patients who participated in this study 
had a life expectancy of only a few months (Hoskin, 1988; 
Quilty et al., 1994) and the main objective of therapy was 
lo provide pain relief while sparing them the extra burden 
of ineffective treatment. For the definition of a complete 
response to radiotherapy, it is necessary to apply strict 
criteria. In this study, we employed the following defini­
tion for a complete response: the patient had to become 
completely pain-free within 28 days after the start of treat­
ment; this was achieved in less than 25% of the cases.
Four patients experienced a type of pain, which fulfilled 
the criteria of neurogenic: neuro-anatomically projected 
pain and signs of neural dysfunction. All the other patients 
had a nociceptive type of pain or a combination of both 
nociceptive and neurogenic, The radiating component of 
the pain was not considered to be an exclusive part of the 
neurogenic type of pain. Patients with a nociceptive pain 
could notify a radiating component that could be described 
as spreading according to nerve pathways or as extending 
beyond the limits of the primary site. It is often impossible 
to make a clear distinction between these two types of pain 
in cancer. No doubt this is due to the diffusely infiltrating 
growth pattern of neoplasms.
Of all the explanatory variables analysed, only the char­
acteristics of pain itself (the presence of radiating pain and 
the pain score (NRS) before radiotherapy) proved to cor­
relate with a complete response to radiotherapy.
In the literature, various non-randomised (prospective 
and retrospective) and randomised studies have described 
the efficacy of radiotherapy for providing cancer pain 
relief (Hoskin, 1988). Owing to different methods of 
pain assessment, possible changes in analgesic consump­
tion during the evaluation period, heterogeneity of patient 
groups and radiotherapy techniques, it is not possible to 
draw conclusions about which radiotherapy technique is 
the best for relieving cancer pain and which variables are 
the most reliable predictors of efficacy.
Our study differed from the ones mentioned above on 
one specific aspect: we concentrated on exploring the 
value of explanatory variables which are related to pain. 
The study design was similar regarding other aspects, 
because patient selection was applied and we prescribed 
a pragmatic treatment technique.
The advanced stage of the primary disease in our 
patients and their poor general condition explained why 
24 out of the 75 patients were unable to complete treat­
ment. Similar drop-out rates have been reported in the 
studies by Price et al. (1986) and Tong et al. (1982). 
They found that using a self-assessment technique led to 
a decrease in compliance to less than 50% three months
after treatment. In the study by Price et al., 30% of the 
patients died within three months of randomisation.
In our patient group, a complete response was observed 
in only 23.5%, which ranks among the lowest success rates 
reported in the literature. The use of strict criteria for the 
definition of a complete response (NRS = 0, within 28 
days) and the pain assessment method may have been 
responsible for this outcome. Pain was assessed by the 
patient, not by a physician. In other studies in which 
pain was assessed by a physician, the response rates 
were higher, whereas in studies which employed self- 
assessment the apparent success rates of radiotherapy 
were lower (Hoskin, 1988).
In patients with a limited life expectancy, it is important 
for therapy to provide rapid pain relief. To avoid applying 
treatment which will be ineffective, explanatory variables 
are needed which can predict efficacy. In agreement with 
other authors, we found that the primary tumour character­
istics and radiotherapy technique did not have any predic­
tive value (Hoskin, 1991). The response rates were the 
same for tumour doses of <8 Gy and >8  Gy. An important 
finding in our study was that pain characteristics did have 
significant predictive value. The chance of achieving a 
complete response was highest in the patients with radiat­
ing pain and a low pain score before radiotherapy 
(NRS < 35). These two pain characteristics have not 
been mentioned before as explanatory variables to predict 
efficacy and they may also indicate that radiotherapy has a 
fairly low analgesic effect.
In our animal experiments we found that irradiating the 
lumbar enlargement of the spinal cord with doses of 10, 15 
and 17.5 Gy inhibited the behavioural response to pain 
stimuli (Rutten et al., 1994). We suggested that this anti­
nociceptive effect was caused by destruction and exhaus­
tion of the resources for neuro-transmission within the 
system which processes and transmits the pain signal.
An explanation of the usefulness of only radiating pain 
and low pain score and not any of the other pain charac­
teristics as explanatory variables may be that different 
biochemical processes are responsible for the different 
pain characteristics. There were several analogies between 
the results of this study and those of our animal experi­
ments. Firstly, the rats which were irradiated in our pre­
vious study did not have malignant tumours and it is 
known that tumour shrinkage is not an essential compo­
nent of the initial analgesic response to radiotherapy. For 
example, rapid onset of pain relief has been observed after 
hypophysectomy, orchidectomy and half-body irradiation 
(Smith and Macaulay, 1985; Hoskin, 1988). Secondly, the 
effect in rats was evident in the hot-plate test but not in the 
tail-flick test, which indicates that the effect may be spe­
cific to certain pain characteristics. Therefore, it can be 
expected that pain characteristics will also be relevant 
explanatory variables in man. Thirdly, the maximum 
effect of irradiation in rats was a reduction in the beha­
vioural response of approximately 50%. Thus, like in man,
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the analgesic efficacy of radiotherapy was limited. In our 
opinion, to determine the exact mechanism of the analge­
sic effect of radiotherapy in man, attention should be 
focused on pain mechanisms rather than on the mechan­
isms involved in destroying tumour cells.
5. Conclusion
In this study on 51 patients, we found a significant rela­
tionship between pain characteristics (the presence of 
radiating pain and a low NRS score before treatment) 
and a complete response to palliative radiotherapy.
Future research should concentrate on the dynamic 
interactions between cancer, pain signal processing and 
irradiation to improve the reliability of explanatory vari­
ables for predicting the efficacy of palliative radiotherapy.
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